title: Oral trimethoprim/sulfamethoxazole in the treatment of acne vulgaris.
abstract: Oral trimethoprim/sulfamethoxazole (TMP-SMX) is approved by the US Food and Drug Administration for the treatment of urinary tract infections, shigellosis, acute otitis media in pediatric patients, and Pneumocystis carinii pneumonia. TMP-SMX has been used off label in dermatology to treat various skin conditions, including acne vulgaris and other skin and soft tissue infections, especially those infections caused by methicillin-resistant Staphylococcus aureus.
authors: Valley Hospital Medical Center, Las Vegas, Nevada, USA.
authors: Sanjay
authors: S
authors: Bhambri
authors: James Q
authors: JQ
authors: Del Rosso
authors: Avani
authors: A
authors: Desai
mesh_terms: D000152:Acne Vulgaris / Q000188:drug therapy*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D000890:Anti-Infective Agents; D015662:Trimethoprim, Sulfamethoxazole Drug Combination